Transcept Pharmaceuticals upgraded to Buy from Hold at MLV Equity MLV Equity upgraded Transcept Pharmaceuticals citing expectations for an FDA approval of the company's insomnia treatment Intermezzo. http://finance.yahoo.com/news/Transcept-Pharmaceuticals-theflyonthewall-3054209051.html?x=0&.v=1